Sandro Hoffmann

Sandro Hoffmann is a skilled scientist specializing in infectious disease vaccines at BioNTech SE since October 2023. Previously, Sandro Hoffmann pursued a PhD in B cell immunology at the DKFZ German Cancer Research Center from October 2019 to September 2023, after completing a Master’s degree in Biomolecular Engineering at Technische Universität Darmstadt between April 2017 and August 2019. Sandro Hoffmann also has experience as a Master Student and Research Intern at DKFZ, a Working Student at Merck KGaA, and completed an internship and Bachelor Thesis at N-zyme Biotec GmbH while collaborating with the Max Rubner Institute. The academic journey includes a Bachelor’s degree in Biotechnology from Darmstadt University of Applied Sciences and vocational training as a biology laboratory assistant at DKFZ. Prior educational achievements consist of a technical diploma and secondary school education.